mTBI - Mild Traumatic Brain Injury
0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
MindRhythmCA - Cupertino
1 programMindRhythm Detection of Concussion and Recovery StudyN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
MindRhythmMindRhythm Detection of Concussion and Recovery Study
iNova PharmaceuticalsPositive Assurance
Clinical Trials (2)
Total enrollment: 379 patients across 2 trials
MindRhythm Detection of Concussion and Recovery Study
Start: Jan 2025Est. completion: Mar 2027150 patients
N/ARecruiting
Positive Assurance and mTBI
Start: Oct 2021Est. completion: Oct 2027229 patients
N/AActive Not Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 379 patients
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.